Comparative Study of Two Marketed 1-day Soft Contact Lenses

Overseen by Thao N Yeh, OD

Age: 18 - 65

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: CooperVision International Limited (CVIL)

No Placebo Group

Trial Summary

What is the purpose of this trial?

This study is designed to evaluate ocufilcon D lens compared to ocufilcon B lens in a 1-week crossover, daily wear regimen.

Research Team

Thao N Yeh, OD

Principal Investigator

U.C. Berkeley, School of Optometry

Eligibility Criteria

Inclusion Criteria

Has had a self reported oculo-visual examination in the last two years.

Is able to wear the study lenses for at least eight hours a day, seven days a week

Aged 18-40 years and has full legal capacity as a volunteer

Treatment Details

Interventions

• ocufilcon B (Soft Contact Lens)
• ocufilcon D (Soft Contact Lens)

Participant Groups

Group I: ocufilcon D Experimental Treatment 1 Intervention

Participants wear a first pair of lenses for one week and then crossover and wear an alternate second pair of lenses for one week.

Group II: ocufilcon B Active Control 1 Intervention

Participants wear a first pair of lenses for one week and then crossover and wear an alternate second pair of lenses for one week.

Who Is Running the Clinical Trial?

CooperVision International Limited (CVIL)

Lead Sponsor

Trials

171

Recruited

14,600+

Dr. Patrizia Cavazzoni

CooperVision International Limited (CVIL)

Chief Medical Officer

MD from Harvard Medical School

Steven Robins

CooperVision International Limited (CVIL)

President, Americas

Bachelor of Arts from Bates College, participated in Pfizer Global Leadership Program with Harvard University

CooperVision, Inc.

Lead Sponsor

Coopervision, Inc.

Lead Sponsor

Trials

164

Recruited

14,200+

Steven Robins

Coopervision, Inc.

Chief Executive Officer

Bachelor of Arts from Bates College, Pfizer Global Leadership Program with Harvard University

Dr. Patrizia Cavazzoni

Coopervision, Inc.

Chief Medical Officer

MD from Harvard Medical School